The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biomarker Test Market Research Report 2025
Synopsis
Most healthcare experts use analysis assessments to make clear and aid their scientific choice making. Steadily over latest years, the analytic manner has turned out to be more potent by means of the need to preselect sufferers in mild of medicines and licenses. This flow has come to through various factors, which include propelling generation (empowering specialists to degree more particular markers of adequacy), an elevated comprehension of the disease manner, and a more outstanding electricity approximately the individuality of an individual’s tumor at the molecular degree.
The global Biomarker Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biomarker Test in Pharma & Biotech Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biomarker Test include F. Hoffmann-La Roche, Novartis, PFIZER, GlaxoSmithKline, GE Healthcare, Medtronics and Quest Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomarker Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Test.
Report Scope
The Biomarker Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biomarker Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Novartis
PFIZER
GlaxoSmithKline
GE Healthcare
Medtronics
Quest Diagnostics
Segment by Type
Cancer
Cardiovascular
Infectious Diseases
Central Nervous System
Segment by Application
Pharma & Biotech Companies
Diagnostic Tool Companies
Healthcare IT/Big Data Companies
Clinical Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Most healthcare experts use analysis assessments to make clear and aid their scientific choice making. Steadily over latest years, the analytic manner has turned out to be more potent by means of the need to preselect sufferers in mild of medicines and licenses. This flow has come to through various factors, which include propelling generation (empowering specialists to degree more particular markers of adequacy), an elevated comprehension of the disease manner, and a more outstanding electricity approximately the individuality of an individual’s tumor at the molecular degree.
The global Biomarker Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biomarker Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biomarker Test in Pharma & Biotech Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biomarker Test include F. Hoffmann-La Roche, Novartis, PFIZER, GlaxoSmithKline, GE Healthcare, Medtronics and Quest Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomarker Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Test.
Report Scope
The Biomarker Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biomarker Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Novartis
PFIZER
GlaxoSmithKline
GE Healthcare
Medtronics
Quest Diagnostics
Segment by Type
Cancer
Cardiovascular
Infectious Diseases
Central Nervous System
Segment by Application
Pharma & Biotech Companies
Diagnostic Tool Companies
Healthcare IT/Big Data Companies
Clinical Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cancer
1.2.3 Cardiovascular
1.2.4 Infectious Diseases
1.2.5 Central Nervous System
1.3 Market by Application
1.3.1 Global Biomarker Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharma & Biotech Companies
1.3.3 Diagnostic Tool Companies
1.3.4 Healthcare IT/Big Data Companies
1.3.5 Clinical Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Test Market Perspective (2019-2030)
2.2 Biomarker Test Growth Trends by Region
2.2.1 Global Biomarker Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biomarker Test Historic Market Size by Region (2019-2024)
2.2.3 Biomarker Test Forecasted Market Size by Region (2025-2030)
2.3 Biomarker Test Market Dynamics
2.3.1 Biomarker Test Industry Trends
2.3.2 Biomarker Test Market Drivers
2.3.3 Biomarker Test Market Challenges
2.3.4 Biomarker Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Test Players by Revenue
3.1.1 Global Top Biomarker Test Players by Revenue (2019-2024)
3.1.2 Global Biomarker Test Revenue Market Share by Players (2019-2024)
3.2 Global Biomarker Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biomarker Test Revenue
3.4 Global Biomarker Test Market Concentration Ratio
3.4.1 Global Biomarker Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Test Revenue in 2023
3.5 Biomarker Test Key Players Head office and Area Served
3.6 Key Players Biomarker Test Product Solution and Service
3.7 Date of Enter into Biomarker Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Test Breakdown Data by Type
4.1 Global Biomarker Test Historic Market Size by Type (2019-2024)
4.2 Global Biomarker Test Forecasted Market Size by Type (2025-2030)
5 Biomarker Test Breakdown Data by Application
5.1 Global Biomarker Test Historic Market Size by Application (2019-2024)
5.2 Global Biomarker Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biomarker Test Market Size (2019-2030)
6.2 North America Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biomarker Test Market Size by Country (2019-2024)
6.4 North America Biomarker Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Test Market Size (2019-2030)
7.2 Europe Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biomarker Test Market Size by Country (2019-2024)
7.4 Europe Biomarker Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Test Market Size (2019-2030)
8.2 Asia-Pacific Biomarker Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biomarker Test Market Size by Region (2019-2024)
8.4 Asia-Pacific Biomarker Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Test Market Size (2019-2030)
9.2 Latin America Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biomarker Test Market Size by Country (2019-2024)
9.4 Latin America Biomarker Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Test Market Size (2019-2030)
10.2 Middle East & Africa Biomarker Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biomarker Test Market Size by Country (2019-2024)
10.4 Middle East & Africa Biomarker Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Biomarker Test Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Biomarker Test Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Biomarker Test Introduction
11.2.4 Novartis Revenue in Biomarker Test Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 PFIZER
11.3.1 PFIZER Company Detail
11.3.2 PFIZER Business Overview
11.3.3 PFIZER Biomarker Test Introduction
11.3.4 PFIZER Revenue in Biomarker Test Business (2019-2024)
11.3.5 PFIZER Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Biomarker Test Introduction
11.4.4 GlaxoSmithKline Revenue in Biomarker Test Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Biomarker Test Introduction
11.5.4 GE Healthcare Revenue in Biomarker Test Business (2019-2024)
11.5.5 GE Healthcare Recent Development
11.6 Medtronics
11.6.1 Medtronics Company Detail
11.6.2 Medtronics Business Overview
11.6.3 Medtronics Biomarker Test Introduction
11.6.4 Medtronics Revenue in Biomarker Test Business (2019-2024)
11.6.5 Medtronics Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Detail
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Biomarker Test Introduction
11.7.4 Quest Diagnostics Revenue in Biomarker Test Business (2019-2024)
11.7.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
